Nitric Oxide-based Possibilities for Pharmacotherapy

References

• Palmer R MJ, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–6
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–41
   PubMed Web of Science ®Google Scholar
• Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051–64
   PubMed Web of Science ®Google Scholar
• Lowenstein C J, Dinerman J L, Snyder S H. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120: 227–37
   PubMed Web of Science ®Google Scholar
• Marietta M A. Approaches toward selective inhibition of nitric oxide synthase. J Med Chem 1994; 37: 1899–1907
   PubMed Web of Science ®Google Scholar
• Palmer R MJ, Ashton D S, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–6
   PubMed Web of Science ®Google Scholar
• White K A, Marietta M A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 1992; 31: 6627–31
   PubMed Web of Science ®Google Scholar
• McMillan K, Bredt D S, Hirsch D J, Snyder S H, Clark J E, Masters B S. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci USA 1992; 89: 11141–5
   PubMed Web of Science ®Google Scholar
• Bredt D S, Hwang P M, Glatt C E, Lowenstein C, Reed R R, Snyder S H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714–8
   PubMed Web of Science ®Google Scholar
• Nishida K, Harrison D G, Navas J P, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092–6
   PubMed Web of Science ®Google Scholar
• Sessa W C, Harrison J K, Barber C M, et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 1992; 267: 15274–6
   PubMed Web of Science ®Google Scholar
• Xie Q-W, Cho H J, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225–8
   PubMed Web of Science ®Google Scholar
• Janssens S P, Shimouchi A, Quertermous T, Bloch D B, Bloch K DB. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519–22
   PubMed Web of Science ®Google Scholar
• Marietta M A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994; 78: 927–30
   PubMed Web of Science ®Google Scholar
• Griffith T M, Edwards D H, Davies R LI, Harrison T J, Evans K T. EDRF coordinates the behaviour of vascular resistance vessels. Nature 1987; 329: 442–5
   PubMed Web of Science ®Google Scholar
• Hecker M, Mülsch A, Bassenge E, Busse R. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol 1993; 265: H828–33
   PubMed Web of Science ®Google Scholar
• Bredt D S, Hwang P M, Snyder S H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768–70
   PubMed Web of Science ®Google Scholar
• Schini V B, Vanhoutte P M. L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat. Circ Res 1991; 68: 209–16
   PubMed Web of Science ®Google Scholar
• Lorsbach R B, Russell S W. A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages. Infect Immun 1992; 60: 2133–5
   PubMed Web of Science ®Google Scholar
• Warren J B, Pons F, Brady A JB. Nitric oxide biology: implications for cardiovascular therapeutics. Cardiovasc Res 1994; 28: 25–30
   PubMed Web of Science ®Google Scholar
• Newman C M, Warren J B, Taylor G W, Boobis A R, Davies D S. Rapid tolerance to the hypotensive effects of glyceryl trinitrate in the rat: prevention by N-acetyl-L- but not N-acetyl-D-cysteine. Br J Pharmacol 1990; 99: 825–9
   Google Scholar
• Bates J N, Baker M T, Guerra R, Harrison D G. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 1991; 42: S157–65
   PubMed Web of Science ®Google Scholar
• Feelisch M, Ostrowski J, Noack E. On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 1989; 14: S13–22
   PubMedGoogle Scholar
• Rehse K, Schlelfer K J, Martens A, Kampfe M. New NO-donors with antithrombotic and vasodilating activities. 5. Oligonitroso sydnone imines. Arch Pharm (Weinheim) 1994; 327: 393–7
   Google Scholar
• Noack E, Feelisch M. Molecular aspects underlying the vasodilator action of molsidomine. J Cardiovasc Pharmacol 1989; 14: S1–5
   PubMedGoogle Scholar
• Myers P R, Minor R U, Guerra R J, Bates J N, Harrison D G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990; 345: 161–3
   PubMed Web of Science ®Google Scholar
• Langford E J, Brown A S, Wainwright R J, et al. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet 1994; 344: 1458–60
   PubMed Web of Science ®Google Scholar
• Siegfried M R, Carey C, Ma X L, Lefer A M. Beneficial effects of SPM-5185, a cystene-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol 1992; 263: H771–7
   Google Scholar
• Yusuf S. The use of beta adrenergic blocking agents, i.v. nitrates, and calcium channel blocking agents following acute myocardial infarction. Chest 1988; 93: 25–8
   PubMed Web of Science ®Google Scholar
• Liu S F, Crawley D E, Barnes P J, Evans T W. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 1991; 143: 32–7
   PubMedGoogle Scholar
• Archer S L, Tolins J R, Raij L, Weir K E. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun 1989; 164: 1198–205
   PubMed Web of Science ®Google Scholar
• Robertson B E, Warren J B, Nye P C. Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs. Exp Physiol 1990; 75: 255–7
   PubMed Web of Science ®Google Scholar
• Frostell C, Fratacci M-D, Wain J C, Jones R, Zapol W M. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038–47
   PubMed Web of Science ®Google Scholar
• Foubert L, Fleming B, Latimer R, et al. Safety guidelines for use of nitric oxide. Lancet 1992; 339: 1615–6
   PubMed Web of Science ®Google Scholar
• Pepke-Zaba J, Higenbottam T W, Dinh-Xuan A T, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173–4
   PubMed Web of Science ®Google Scholar
• Roberts J D, Polaner D M, Lang P, Zapol W M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancer 1992; 340: 818–9
   PubMed Web of Science ®Google Scholar
• Pearl R G. Inhaled nitric oxide. The past, the present, and the future. Anesthesiology 1993; 78: 413–6
   Google Scholar
• Weitzberg E, Rudehill A, Lundberg J M. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 1993; 233: 85–94
   PubMed Web of Science ®Google Scholar
• Drexler H, Zeiher A M, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546–50
   PubMed Web of Science ®Google Scholar
• Girerd X J, Hirsch A T, Cooke J P, Dzau V J, Creager M A. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990; 67: 1301–8
   PubMed Web of Science ®Google Scholar
• Weyrich A S, Ma X, Lefer A M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86: 279–88
   PubMed Web of Science ®Google Scholar
• Pernow J, Uriuda Y, Wang Q-D, Li X-S, Nordlander R, Rydén L. The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J 1994; 15: 1712–9
   PubMedGoogle Scholar
• Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of L-arginine nitric oxide pathway in hypertension. J Hypertens 1993; 11: 639–45
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Hirooka Y, Masaki H, et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992; 20: 511–7
   PubMed Web of Science ®Google Scholar
• Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991; 81: 695–700
   Google Scholar
• Förstermann U, Closs E I, Pollock J S, et al. Nitric oxide synthase isoenzymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121–31
   PubMed Web of Science ®Google Scholar
• Hecker M, Mitchell J A, Harris H J, Katsura M, Thiemermann C, Vane J R. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun 1990; 167: 1037–43
   PubMed Web of Science ®Google Scholar
• Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20: S60–2
   PubMed Web of Science ®Google Scholar
• Furchgott R F, Zawadski D. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–6
   PubMed Web of Science ®Google Scholar
• Furchgott R F. Role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984; 24: 175–97
   PubMed Web of Science ®Google Scholar
• Bönner G, Preis S, Schunk U, Toussaint C, Kaufmann W. Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 1990; 15: 175–80
   Google Scholar
• Hecker M, Pörsti I, Bara A T, Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br J Pharmacol 1994; 111: 238–44
   PubMed Web of Science ®Google Scholar
• Busse R, Fleming I. The endothelial organ. Curr Opin Cardiol 1993; 8: 719–27
   Google Scholar
• Ferreira S H. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol 1965; 24: 163–9
   PubMed Web of Science ®Google Scholar
• Hecker M, Fleming I, Pörsti I, Busse R. ACE inhibitors, kinins and endothelial autacoid formation. Pharm Pharmacol Lett 1993; 3: 64–7
   Google Scholar
• Linz W, Schölkens B A. A specific B2-bradykinin antagonist HOE-140 abolishes antihypertrophic effect of ramipril. Br J Pharmacol 1992; 105: 771–2
   PubMed Web of Science ®Google Scholar
• Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Biihler F R. Blood pressure control by the reninangiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation 1992; 85: 1–8
   PubMed Web of Science ®Google Scholar
• Arvola P, Ruskoaho H, Wuorela H, Pekki A, Vapaatalo H, Pörsti I. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br J Pharmacol 1993; 108: 980–90
   PubMed Web of Science ®Google Scholar
• Hirooka Y, Imaizumi T, Masaki H, et al. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992; 20: 175–80
   PubMed Web of Science ®Google Scholar
• Martorana P A, Kettenbach B, Breipohi G, Linz W, Schölkens B A. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 1990; 182: 395–6
   PubMed Web of Science ®Google Scholar
• Becker R H, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol 1991; 18: S110–5
   Google Scholar
• Scholkens B A, Linz W, Martorana P A. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction. J Cardiovasc Pharmacol 1991; 18: S26–30
   Google Scholar
• Kahönen M, Arvola P, Mäkynen H, Pörsti I. Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats. Br J Pharmacol 1994; 112: 925–33
   Google Scholar
• Mehta J L, Lopez L M, Chen L, Cox O E. Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effect of celiprolol. Am J Cardiol 1994; 74: 901–5
   PubMed Web of Science ®Google Scholar
• Kähönen M, Arvola P, Mäkynen H, Wuorela H, Pörsti I. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats. J Pharmacol Exp Ther 1995, (in press)
   Google Scholar
• Treasure C B, Klein J L, Weintraub W S, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary arterial disease. N Engl J Med 1995; 332: 481–7
   PubMed Web of Science ®Google Scholar
• Loscalzo J, Smick D, Andon N, et al. S-nitrosocaptopril: molecular characterization and effects on the vasculature and on platelets. J Pharmacol Exp Ther 1989; 249: 726–9
   PubMed Web of Science ®Google Scholar
• Shaffer J E, Lee F, Thomson S, et al. The hemodynamic effects of S-nitrosocaptopril in anesthetized dogs. J Pharmacol Exp Ther 1990; 256: 704–9
   Google Scholar
• Ishii K, Chang B, Kerwin J F, Jr, Huang Z-J, Murad F. Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 1990; 176: 219–23
   PubMed Web of Science ®Google Scholar
• Gross S S, Jaffe E A, Levi R, Kilbourn R G. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 1991; 178: 823–9
   PubMed Web of Science ®Google Scholar
• Martin G R, Bofolo M L, Giles H. Inhibition of endothelium-dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence. Br J Pharmacol 1992; 105: 643–52
   Google Scholar
• Frew J D, Paisley K, Martin W. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine. Br J Pharmacol 1993; 110: 1003–8
   PubMed Web of Science ®Google Scholar
• Feldman P L, Griffith O W, Hong H, Stuehr D J. Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation. J Med Chem 1993; 36: 491–6
   PubMed Web of Science ®Google Scholar
• McCall T B, Feelisch M, Palmer R M, Moncada S. Identification of N-iminoethyl-L-omithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol 1991; 102: 234–8
   PubMed Web of Science ®Google Scholar
• Bogle R G, Moncada S, Pearson J D, Mann G E. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 1992; 105: 768–70
   PubMed Web of Science ®Google Scholar
• Olken N M, Marietta M A. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry 1993; 32: 9677–85
   PubMed Web of Science ®Google Scholar
• Buxton I LO, Cheek D J, Eckman D, Westfall D P, Sanders K M, Keef K D. NG-nitro L-arginine methyl esters and other alkyl esters of arginine are muscarinic receptor anatgonists. Circ Res 1993; 72: 387–95
   PubMed Web of Science ®Google Scholar
• Winn M J, Asante N K, Ku D D. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and Nω-nitro-L-arginine methyl ester. J Pharmacol Exp Ther 1993; 264: 265–70
   Google Scholar
• Koller A, Sun E, Messina E J, Kaley G. L-arginine analogues blunt prostaglandin-related dilation of arteries. Am J Physiol 1993; 264: H1194–9
   PubMed Web of Science ®Google Scholar
• Pou S, Pou W S, Bredt D S, Snyder S H, Rosen G M. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 1992; 267: 24173–6
   PubMed Web of Science ®Google Scholar
• Nava E, Palmer R M, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?. Lancet 1991; 338: 1555–7
   PubMed Web of Science ®Google Scholar
• Kilbourn R G, Jubran A, Gross S S, et al. Reversal of endotoxin mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132–8
   PubMed Web of Science ®Google Scholar
• Petros A, Bennet D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancer 1991; 338: 1557–8
   PubMed Web of Science ®Google Scholar
• Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34–9
   PubMed Web of Science ®Google Scholar
• Klabunde R E, Ritger R C. NG-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 1991; 178: 1135–40
   Web of Science ®Google Scholar
• Rees D D, Cellek S, Palmer R M, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173: 541–7
   PubMed Web of Science ®Google Scholar
• Schulz R, Nava E, Moncada S. Induction and potential biological relevance of a Ca2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105: 575–80
   PubMed Web of Science ®Google Scholar
• Radomski M W, Palmer R M, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043–7
   PubMed Web of Science ®Google Scholar
• Knowles R G, Salter M, Brooks S L, Moncada S. Antiinflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 1990; 172: 1042–8
   PubMed Web of Science ®Google Scholar
• Brady A JB, Poole-Wilson P A, Harding S E, Warren J B. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992; 263: H1963–6
   PubMed Web of Science ®Google Scholar
• Smith R E, Palmer R M, Moncada S. Coronary vasodilatation induced by endotoxin in the rabbit isolated perfused heart is nitric oxide-dependent and inhibited by dexamethasone. Br J Pharmacol 1991; 104: 5–6
   Google Scholar
• Pons F, Williams T J, Warren J B. Nitric oxide, but not interleukin-1, mediates the local blood flow response to lipopolysaccharide in rabbit skin. Eur J Pharmacol 1993; 239: 23–30
   Google Scholar
• Warren J B, Lol R K, Coughlan M L. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin In vivo. Br J Pharmacol 1993; 109: 802–6
   PubMed Web of Science ®Google Scholar
• Williams J K, Adams M R, Herrington D M, Clarkson T B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992; 20: 452–7
   PubMed Web of Science ®Google Scholar
• Reis S E, Gloth S T, Blumenthal R S, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52–60
   PubMed Web of Science ®Google Scholar
• Lieberman E H, Gerhard M D, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936–41
   PubMed Web of Science ®Google Scholar
• Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994; 90: 1964–8
   PubMed Web of Science ®Google Scholar
• Mitchell J A, de Nucci G, Warner T D, Vane J R. Different patterns of release of endothelium-derived relaxing factor and prostacyclin. Br J Pharmacol 1992; 105: 485–9
   PubMed Web of Science ®Google Scholar
• Braun M, Schrör K. Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res 1992; 71: 1305–13
   Google Scholar
• de Nucci G, Gryglewski R J, Warner T D, Vane J R. Receptor mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988; 85: 2334–8
   PubMed Web of Science ®Google Scholar
• Warren J B, Coughlan M L, Williams T J. Endotoxin-induced vasodilation in anesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br J Pharmacol 1992; 106: 953–7
   PubMed Web of Science ®Google Scholar
• Griffiths M JD, Messent M, Mac Allister R J, Evans T W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110: 963–8
   PubMed Web of Science ®Google Scholar
• Misko T P, Moore W M, Kasten T P, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119–25
   PubMed Web of Science ®Google Scholar
• Wolff D J, Datto G A, Samatovicz R A. The dual mode of inhibition of calmodulin-dependent nitric oxide synthase by antifungal imidazole agents. J Biol Chem 1993; 268: 9430–6
   Google Scholar
• Stuehr D J, Fasehun O A, Kwon N S, et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 1991; 5: 98–103
   PubMed Web of Science ®Google Scholar
• Wang Y-X, Pang C CY. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J Pharmacol Exp Ther 1993; 265: 263–72
   PubMed Web of Science ®Google Scholar
• Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367–74
   PubMed Web of Science ®Google Scholar
• McCall T, Vallance P. Nitric oxide takes centre-stage with newly defined roles. Trends Pharmacol 1992; 13: 1–6
   PubMed Web of Science ®Google Scholar
• Marczin N, Papapetropoulos A, Jilling T, Catravas J D. Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents. Br J Pharmacol 1993; 109: 603–5
   PubMed Web of Science ®Google Scholar
• Yoshida M, Akaike T, Wada Y, et al. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 1994; 202: 923–30
   PubMed Web of Science ®Google Scholar
• Radomski M W, Palmer R MJ, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639–46
   PubMed Web of Science ®Google Scholar
• Smith J A, Shah A M, Lewis M J. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 1991; 439: 1–14
   PubMed Web of Science ®Google Scholar
• Dinerman J L, Lowenstein C J, Snyder S H. Molecular mechanisms of nitric oxide regulation. Circ Res 1993; 73: 217–22
   PubMed Web of Science ®Google Scholar
• Faraci F M, Breese K R. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 1993; 72: 476–80
   PubMed Web of Science ®Google Scholar
• Toda N, Okamura T. Mechanism underlying the response to vasodilator nerve stimulation in isolated dog and monkey cerebral arteries. Am J Physiol 1990; 259: H1511–7
   PubMed Web of Science ®Google Scholar
• Baumann J E, Persson P B, Ehmke H, Nafz B, Kirchbelm H R. Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs. Am J Physiol 1992; 263: F208–13
   PubMedGoogle Scholar
• Yukimura T, Yamashita Y, Miura K, Okumura M, Yamanaka S, Yamamoto K. Renal effects of the nitric oxide synthase inhibitor L-NG-nitroarginine, in dogs. Am J Hypertens 1992; 5: 484–7
   PubMed Web of Science ®Google Scholar
• Deng A, Baylis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol 1993; 264: F212–5
   PubMed Web of Science ®Google Scholar
• Fineman J R, Heymann M A, Soifer S J. N-omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol 1991; 260: H1299–306
   PubMed Web of Science ®Google Scholar
• Chu A, Chambers D E, Lin C C, Kuehl W D, Cobb F R. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol 1990; 258: H1250–4
   PubMed Web of Science ®Google Scholar
• Broten T P, Miyashiro J K, Moncada S, Feigl E O. Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilation. Am J Physiol 1992; 262: H1579–84
   Google Scholar
• Amezcua J L, Palmer R M, de Souza B M, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1989; 97: 1119–24
   PubMed Web of Science ®Google Scholar
• Jones L F, Brody M J. Coronary blood flow in rats is dependent on the release of vascular nitric oxide. J Pharmacol Exp Ther 1992; 260: 627–31
   Google Scholar
• Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992; 263: G149–54
   Google Scholar
• Nozaki K, Moskowitz M A, Maynard Kl, et al. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J Cereb Blood Flow Metab 1993; 13: 70–9
   PubMed Web of Science ®Google Scholar
• Rees D D, Palmer R MJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375–8
   PubMed Web of Science ®Google Scholar
• Lüscher T F. Heterogeneity of endothelial dysfunction in hypertension. Eur Heart J 1992; 13(Suppl D)50–5
   PubMed Web of Science ®Google Scholar
• Calver A, Collier J, Moncada S, Vallance P. Effect of local intraarterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025–31
   PubMed Web of Science ®Google Scholar
• Lüscher T F, Tanner F C, Dohi Y. Age hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. Pharmacol Toxicol 1992; 70: S32–9
   Google Scholar
• Panza J A, Quyyumi A A, Brush J E, Epstein S E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–7
   PubMed Web of Science ®Google Scholar
• Panza J A, Casino P R, Kilcoyne C M, Quyyumi A A. Role of endothelium derived nitric oxide in the abnormal endothelium dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468–74
   PubMed Web of Science ®Google Scholar
• Lüscher T F, Tanner F C, Tschudl M R, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993; 44: 395–418
   PubMed Web of Science ®Google Scholar
• Chester A H, O'Neil G S, Moncada S, Tadjkarimi S, Yacoub M H. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990; 336: 897–900
   PubMed Web of Science ®Google Scholar
• Creager M A, Cooke J P, Mendelsohn M E, et al. Impaired vasodilation of forearm resistance vessels in hyper-cholesterolemic humans. J Clin Invest 1990; 86: 228–34
   PubMed Web of Science ®Google Scholar
• Chowienczynk P J, Watts G F, Cockroft J R, Ritter J M. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430–2
   Google Scholar
• Jacobs M, Plane F, Bruckdorfer K R. Native and oxidized low density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol 1990; 100: 21–6
   PubMed Web of Science ®Google Scholar
• Plane F, Bruckdorfer K R, Kerr P, Steuer A, Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol 1992; 105: 216–22
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993; 362: 801–9
   PubMed Web of Science ®Google Scholar
• Vanhoutte P M. The endothelium—modulator of vascular smooth muscle tone. N Engl J Med 1988; 319: 512–3
   PubMed Web of Science ®Google Scholar
• Quyyumi A A, Cannon R O, Panza J A, Diodati J G, Epstein S E. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992; 86: 1864–71
   PubMed Web of Science ®Google Scholar
• LeFroy D C, Crake T, Uren N G, Davies G J, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993; 88: 43–54
   Web of Science ®Google Scholar
• Nakashima M, Mombouli J V, Taylor A A, Vanhoutte P M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993; 92: 2867–71
   PubMed Web of Science ®Google Scholar
• Manderson J A, Cocks T M, Campbell G R. Balloon catheter injury to rabbit carotid artery II. Selective increase in reactivity to some vasoconstrictor drugs. Atherosclerosis 1989; 9: 299–307
   Google Scholar
• Shimokawa H, Aarhus L L, Vanhoutte P M. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res 1987; 61: 256–70
   PubMed Web of Science ®Google Scholar
• Brady A J, Warren J B. Angioplasty and restenosis. BMJ 1991; 303: 729–30
   Google Scholar
• Hogan M, Cerami A, Bucala R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 1992; 90: 1110–5
   PubMed Web of Science ®Google Scholar
• Wakabayashi I, Hatake K, Kimura N, Kakishita E, Nagal K. Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 1987; 40: 643–8
   PubMed Web of Science ®Google Scholar
• Stehouwer C DA, Nauta J JP, Zeldenrust G C, Hackeng W HL, Donker A JM, Den Ottolander G JH. Urinary albumin excretion cardiovascular disease, and endothelial dysfunction in non-insulin dependent diabetes mellitus. Lancet 1992; 340: 319–23
   PubMed Web of Science ®Google Scholar
• Cohen J A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993; 87: 67–76
   Web of Science ®Google Scholar
• Kim Y D, Fomsgaard J S, Heim K F, et al. Brief ischemia reperfusion induces stunning of endothelium in canine coronary artery. Circulation 1992; 85: 1473–82
   Google Scholar
• Brady A J, Williams F M, Williams T J. Inflammatory injury in myocardial ischaemia. Clin Sci (Colch) 1992; 83: 511–8
   Google Scholar
• Tsao P S, Lefer A M. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol 1990; 259: H1660–6
   PubMedGoogle Scholar
• Ma X-I, Weyrich A S, Lefer D J, Lefer A M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993; 72: 403–12
   PubMed Web of Science ®Google Scholar
• Johnson G, Tsao P S, Lefer A M. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991; 19: 244–52
   PubMed Web of Science ®Google Scholar
• Vegh A, Szekeres L, Parratt J R. Preconditioning of the ischaemic myocardium: involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992; 107: 648–52
   PubMed Web of Science ®Google Scholar
• Lipton S A, Yun-Beom C, Pan Z-H, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626–32
   PubMed Web of Science ®Google Scholar
• Winlaw D S, Smythe G A, Keogh A M, Schyvens C G, Spratt P M, Macdonald P S. Increased nitric oxide production in heart failure. Lancet 1994; 344: 373–4
   PubMed Web of Science ®Google Scholar
• De Belder A J, Radomski M W, Why H JF, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993; 341: 84–5
   PubMed Web of Science ®Google Scholar
• Brady A JB, Warren J B, Poole-Wilson P A, Williams T J, Harding S E. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265: H176–82
   PubMed Web of Science ®Google Scholar
• Balligand J-L, Ungureanu D, Kelly R A, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage conditioned medium. J Clin Invest 1993; 91: 2314–9
   PubMed Web of Science ®Google Scholar
• Kubo S H, Rector T S, Bank A J, Williams R E, Helfetz S M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84: 1589–96
   PubMed Web of Science ®Google Scholar
• Drexler H, Hayoz D, Munzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992; 69: 1596–601
   PubMed Web of Science ®Google Scholar
• Lindsay D C, Jiang C, Brunotte F, et al. Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res 1992; 26: 694–7
   PubMed Web of Science ®Google Scholar
• Hayoz D, Drexler H, Munzel T, et al. Flow-mediated arterial dilation is abnormal in congestive heart failure. Circulation 1993; 87: 92–6
   Google Scholar
• Radomski M W, Palmer R M, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193–7
   PubMed Web of Science ®Google Scholar
• Vallance P, Benjamin N, Collier J. The effect of endothelium derived nitric oxide on ex vivo whole blood platelet aggregation in man. Eur J Clin Pharmacol 1992; 42: 37–41
   Google Scholar
• Sneddon J M, Vane J R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988; 85: 2800–4
   PubMed Web of Science ®Google Scholar
• Radomski M W, Palmer R M, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancer 1987; 2: 1057–8
   PubMed Web of Science ®Google Scholar
• Nolte C, Eigenthaler M, Schanzenbacher P, Walter U. Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. J Biol Chem 1991; 266: 14808–12
   PubMed Web of Science ®Google Scholar
• Yamakado T, Nishikawa M, Hidaka H. Stimulation of human platelet guanylate cyclase by nitroso compounds. Thromb Res 1982; 26: 135–40
   Google Scholar
• Durante W, Kroll M H, Vanhoutte P M, Schafer Al. Endothelium derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992; 79: 110–6
   PubMed Web of Science ®Google Scholar
• Ring T, Knudsen F, Kristensen S D, et al. Nitroglycerin prolongs the bleeding time in healthy males. Thromb Res 1983; 29: 553–9
   PubMedGoogle Scholar
• Kanamaru K, Waga S, Kojima T, Fujimoto K, Niwa S. Endothelium-dependent relaxation of canine basilar arteries II. Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 1987; 18: 938–43
   PubMed Web of Science ®Google Scholar
• Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591–5
   PubMed Web of Science ®Google Scholar
• Kilbourn R G, Gross S S, Jubran A, et al. NG-methyl-L-arginine inhibits tumour necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629–32
   PubMed Web of Science ®Google Scholar
• Finkel M S, Oddis C V, Jacob T D, Watkins S C, Hattler B G, Simmons R L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–9
   PubMed Web of Science ®Google Scholar
• Aoki N, Johnson G, Lefer A M. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol 1990; 258: G275–81
   Google Scholar
• Hutcheson I R, Whittle B J, Boughton-Smith N K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815–20
   PubMed Web of Science ®Google Scholar
• Chu Z M, Beilin U. Mechanisms of vasodilation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. Br J Pharmacol 1993; 109: 322–9
   PubMed Web of Science ®Google Scholar
• Conrad K P, Joffe G, Kruszyna H, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7: 566–71
   PubMed Web of Science ®Google Scholar
• Sellgman S P, Buyon J P, Clancy R M, Young B K, Abramson S B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171: 944–8
   Google Scholar
• Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994; 24: 112–29
   PubMed Web of Science ®Google Scholar
• Ikenaga H, Suzuki H, Ishil N, Itoh H, Saruta T. Role of NO on pressure natriuresis in Wistar-Kyoto and spontaeously hypertensive rats. Kidney Int 1993; 43: 205–11
   PubMed Web of Science ®Google Scholar
• Pfeilshcilfer J, Kunz D, Mühl H. Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron 1993; 64: 518–25
   Google Scholar
• Cattelll V, Lianos F, Largen P, Cook T. Glomerular NO synthase activity in mesangial cell immune injury. Exp Nephrol 1993; 1: 38–40
   Google Scholar
• Cartel V, Largen P, De Heer E, Cook T. Glomeruli synthesize nitrite in active Heymann nephritis. The source is infiltrating macrophages. Kidney Int 1991; 40: 847–51
   Google Scholar
• Beasley D, Brenner B M. Role of nitric oxide in hemodialysis hypotension. Kidney Int 1992; 42: S96–100
   Web of Science ®Google Scholar
• Burnett A L, Lowenstein C J, Bredt D S, Chang T S, Snyder S H. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257: 401–3
   PubMed Web of Science ®Google Scholar
• Bush P A, Aronson W J, Buga G M, Rajfer J, Ignarro L J. Nitric oxide is a potent relaxant of human and rabbit corpus cavemosum. J Urol 1992; 147: 1650–5
   PubMed Web of Science ®Google Scholar
• Trigo-Rocha F, Aronson W J, Hohenfellner M, Ignarro L J, Rajfer J, Lue T F. Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. Am J Physiol 1993; 264: H419–22
   PubMed Web of Science ®Google Scholar
• Ånggard E. Nitric oxide: mediator, murderer, medicine. Lancet 1994; 343: 1199–206
   PubMed Web of Science ®Google Scholar
• Young H M, Furness J B, Shuttleworth C W, Bredt D S, Snyder S H. Colocalization of nitric oxide synthase immunoreactivity and NADPH diaphorase staining in neurons of the guinea-pig intestine. Histochemistry 1992; 97: 375–8
   PubMedGoogle Scholar
• Gustafsson L E, Wiklund C U, Wiklund N P, Persson M G, Moncada S. Modulation of autonomic neuroeffector transmission by nitric oxide in guinea pig ileum. Biochem Biophys Res Commun 1990; 173: 106–10
   PubMed Web of Science ®Google Scholar
• Sanders K M, Ward S M, Thornbury K D, Dalziel H H, Westfall D P, Carl A. Nitric oxide as a non-adrenergic, non-cholinergic neurotransmitter in the gastrointestinal tract. Jpn J Pharmacol 1992; 58(Suppl 2)220–5P
   Google Scholar
• Desai K M, Sessa W C, Vane J R. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 1991; 351: 477–9
   PubMed Web of Science ®Google Scholar
• Bult H, Boeckxstaens G E, Pelckmans P A, Jordaens F H, Van Maercke Y M, Herman A G. Nitric oxide as an inhibitory nonadrenergic non-cholinergic neurotransmitter. Nature 1990; 345: 346–7
   PubMed Web of Science ®Google Scholar
• Tottrup A, Glavind E B, Svane D. Involvement of the L-arginine nitric oxide pathway in internal anal sphincter relaxation. Gastroenterology 1992; 102: 409–5
   PubMed Web of Science ®Google Scholar
• Vanderwinden J M, Mailleux P, Schiffman S N, Vanderhaegen J, De Laet M. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med 1992; 327: 511–5
   PubMedGoogle Scholar
• Middleton S J, Shorthouse M, Hunter J D. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341: 465–6
   PubMed Web of Science ®Google Scholar
• Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14: 60–7
   PubMed Web of Science ®Google Scholar
• Breer H, Shephard G M. Implications of NO/cGMP system for olfaction. Trends Neurosci 1993; 16: 5–9
   PubMedGoogle Scholar
• Garthwaite J, Charles S T, Chess-Williams R. Endo-thelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature 1988; 336: 385–8
   PubMed Web of Science ®Google Scholar
• Snyder S H. Nitric oxide: first in a new class of neurotransmitters. Science 1992; 257: 494–6
   PubMed Web of Science ®Google Scholar
• Hope B T, Michael G J, Knigge K M, Vincent S R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 1991; 88: 2811–4
   PubMed Web of Science ®Google Scholar
• Choi D W. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 1990; 10: 2493–501
   PubMed Web of Science ®Google Scholar
• Uemura Y, Kowall N W, Beal M F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol 1990; 27: 620–5
   PubMedGoogle Scholar
• Nowicki J P, Duval D, Polgnet H, Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 1991; 204: 339–40
   PubMed Web of Science ®Google Scholar
• Dawson T M, Dawson V L, Snyder S H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297–311
   PubMed Web of Science ®Google Scholar
• Dawson D A, Kusumoto K, Graham D I, McCulloch J, Macrae I M. Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett 1992; 142: 151–4
   Google Scholar
• Ferrante R J, Kowall N W, Beal M F, Richardson E P, Jr, Bird E D, Martin J B. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985; 230: 561–4
   PubMed Web of Science ®Google Scholar
• Durate I DG, Lorenzetti B B, Ferreira S H. Peripheral analgesia and activation of nitric oxide-cyclic GMP pathway. Eur J Pharmacol 1990; 186: 289–93
   Google Scholar
• Meller S T, Gebhart G F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52: 127–36
   PubMed Web of Science ®Google Scholar
• Tseng L T, Xu J Y, Pieper G M. Increase of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in the mouse. Eur J Pharmacol 1992; 212: 301–3
   PubMed Web of Science ®Google Scholar
• Kolesnikov Y A, Pick C G, Ciszewska G, Pasternak G W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 1993; 90: 5162–6
   PubMed Web of Science ®Google Scholar
• Fortier A H, Polsinelli T, Green S J, Nacy C A. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun 1992; 60: 817–25
   PubMed Web of Science ®Google Scholar
• Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 1991; 132: 150–7
   PubMed Web of Science ®Google Scholar
• Mayer J, Woods M L, Vavrin Z, Hibbs J B, Jr. Gamma interferon induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun 1993; 61: 491–7
   PubMed Web of Science ®Google Scholar
• Alspaugh J A, Granger D L. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991; 59: 2291–6
   PubMedGoogle Scholar
• Green S J, Meltzer M S, Hibbs J B, Jr, Nacy C A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 1990; 144: 278–83
   PubMed Web of Science ®Google Scholar
• Gazzinelli R T, Oswald I P, James S L, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 1992; 148: 1792–6
   PubMed Web of Science ®Google Scholar
• Karupiah G, Xie Q, Buller R ML, Nathan C, Duarte C, Mac Micking J D. Inhibition of viral replication by interferon-gamma induced nitric oxide synthase. Science 1993; 261: 1445–8
   PubMed Web of Science ®Google Scholar
• Hibbs J B, Jr, Taintor R R, Vavrin Z, Rachlin E M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87–94
   PubMed Web of Science ®Google Scholar
• Devlin J, Palmer R MJ, Gonde C E, et al. Nitric oxide generation—A predictive parameter of acute allograft rejection. Transplantation 1994; 58: 592–5
   Google Scholar
• Corbett J A, McDaniel M L. Does nitric oxide mediate autoimmune destruction of β-cells?. Diabetes 1992; 41: 897–903
   PubMed Web of Science ®Google Scholar
• Mulligan M S, Hevel J M, Marietta M A, Ward P A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 1991; 88: 6338–42
   PubMed Web of Science ®Google Scholar
• Masferrer J L, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992; 89: 3917–21
   PubMed Web of Science ®Google Scholar
• Wilson A J, Warren J B. Adenylate cyclase mediated vascular responses of rabbit aorta, mesenteric artery and skin microcirculation. Br J Pharmacol 1993; 110: 633–8
   Google Scholar
• Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211: 177–82
   PubMed Web of Science ®Google Scholar
• Lippe I T, Stabentheiner A, Holzar P. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur J Pharmacol 1993; 232: 113–20
   Google Scholar
• Mulligan M S, Moncada S, Ward P A. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992; 107: 1159–62
   PubMed Web of Science ®Google Scholar
• Warren J B. Vascular control of inflammatory oedema. Clin Sci 1993; 84: 581–4
   Google Scholar
• Schmidt H, Warner T D, Ishli K, Sheng H, Murad F. Insulin secretion from pancreatic β cells caused by L-arginine-derived nitrogen oxides. Science 1992; 255: 721–3
   PubMed Web of Science ®Google Scholar